Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12617000352303
Ethics application status
Approved
Date submitted
9/02/2017
Date registered
8/03/2017
Date last updated
30/01/2020
Date data sharing statement initially provided
13/02/2019
Date results information initially provided
30/01/2020
Type of registration
Prospectively registered
Titles & IDs
Public title
Structured triage and referral to reduce callers’ distress levels when using the Cancer Councils’ 13 11 20 telephone services
Query!
Scientific title
A randomised trial to implement systematic distress screening and structured care for callers using Cancer Councils' telephone services
Query!
Secondary ID [1]
290848
0
APP1112983
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
START (Structured Triage And Referral by Telephone)
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Distress
301527
0
Query!
Cancer
301528
0
Query!
Condition category
Condition code
Cancer
301245
301245
0
0
Query!
Any cancer
Query!
Mental Health
301246
301246
0
0
Query!
Anxiety
Query!
Mental Health
301247
301247
0
0
Query!
Depression
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
This stepped-wedge trial will be conducted in two cancer-specific telephone counselling services and will assess the comparative effectiveness of: i) Treatment as Usual (Arm 1): single-stage distress screening and unstructured referral to Cancer Council internal services; compared with ii) Structured Care (Arm 2): multi-stage distress screening and a structured referral model with follow up monitoring. Both Treatment as Usual (Arm 1) and Structured Care (Arm 2) will be delivered by trained consultants during the course of an inbound telephone call to the New South Wales and Victorian Cancer Councils’ 13 11 20 Cancer Information and Support service.
According to the stepped wedge design, the Structured Care (Arm 2) intervention will be rolled out sequentially over 3 6-month time periods: 1) all consultants will deliver Usual Care (Arm 1) from 0-6 months, 2) half of the consultants will be randomised to deliver Structured Care (Arm 2) and half will continue to deliver Usual Care (Arm 1) from 7-13 months, and 3) all consultants will deliver Structured Care (Arm 2) from 14-20 months. Accounting for a 1-month wash in period between each time period, the trial will be 20 months.
Arm 1 (Treatment as Usual): Depending on the course of the conversation, callers may be offered any of the following existing services by Cancer Council consultants: i) Online peer-based support and information; ii) Face-to-face support groups where people affected by cancer support each other; iii) One-to-one telephone support from a person who has recovered from a similar experience; iv) Telephone support group meetings of 3-7 members and qualified facilitators twice a month; v) referral to social work, legal, financial or transport assistance; vi) cancer survivor programs; vii) information resources; or viii) referral to a counsellor/psychologist. Callers may be offered one or more of these services based on the consultant’s clinical judgement and the caller's level of distress which is measured by a single-item screening tool (the Distress Thermometer [DT]).
Arm 2 (Structured Care): Consultants who are randomised to Arm 2 will administer a two-stage screening process (the DT plus PHQ-4). Based on these results, the consultant will refer to the structured care model and offer the caller those services which align with their level of distress (i.e mild, moderate or severe). The structured care model was developed specifically for this study by the University of Newcastle research team, Cancer Council NSW, and Cancer Council Victoria. Development included: i) a review of existing distress screening and management guidelines including the NCCN guidelines; 2) iterative discussion with place card mapping and think aloud methodology; and 3) pilot-testing.
The structured care model can be supplemented with an additional follow-up call involving repeat screening and further support for those with elevated or unchanged distress scores (i.e. stepped care). Those callers with moderate to severe distress will be offered this additional outbound call; if accepted, the call will be scheduled at least two weeks following the initial inbound call and dependant on other events (such as start or completion of treatment).
Callers allocated to Arm 1 (Treatment as Usual) will not be denied any services. Rather, callers within Arm 1 will not be assessed for service suitability in the systematic and structured fashion which will be the case for Arm 2 (Structured Care).
Intervention fidelity: To assess consultants’ fidelity to administering the DT (Arm 1 and 2), the PHQ-4 (Arm 2 only), and the structured care model (Arm 2 only), the research team will review a random sample of audio recordings. Furthermore, using the Client Record Management Systems it will be possible to audit the proportion of calls in which DT or PHQ-4 scores were recorded; participants will also be asked to report which services were offered during their call at a 3- and 6-month follow up survey.
Query!
Intervention code [1]
296788
0
Early detection / Screening
Query!
Intervention code [2]
296789
0
Treatment: Other
Query!
Intervention code [3]
296790
0
Behaviour
Query!
Comparator / control treatment
Treatment as usual (control): Consultants randomised to this group will refer callers to services based on their clinical judgement and DT scores. Those callers who receive Treatment as usual will not be denied any services. Rather, these callers will not be assessed for service suitability in the systematic and structured fashion which will be the case for the Structured Care group (intervention).
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
300664
0
Primary Outcome 1 (referral uptake). The proportion of participants who were provided with a referral (based on review of call recordings and CRM data) and report that an action has been taken to progress the referral.
Query!
Assessment method [1]
300664
0
Query!
Timepoint [1]
300664
0
3 and 6 months post-recruitment
Query!
Primary outcome [2]
300665
0
Primary Outcome 2 (distress). General psychological distress will be measured by the GHQ-28 (General Health Questionnaire-28) which is a widely used, self-report measure of general psychological distress. The measure takes approximately 5 minutes to complete and uses 28 items to assess perception of health in terms of ability to: play a useful part in life; make decisions; overcome difficulties; enjoy normal activities; face problems; and feel confident, worthwhile, and happy over “the last 4 weeks”. The GHQ-28 has excellent internal consistency, diagnostic accuracy (sensitivity: 0.93; specificity: 0.92), and test-retest reliability. The measure has been validated and used in the Australian community and with cancer patients.
Query!
Assessment method [2]
300665
0
Query!
Timepoint [2]
300665
0
3 and 6 months post recruitment.
Query!
Secondary outcome [1]
330541
0
Secondary outcome 1 (Efficacy and impact of health education). The heiQ (Registered Trademark) is an Australian-developed tool for assessing the efficacy and impact of health education and self-management programs for people with chronic diseases. Its 42 items map to eight domains. The heiQ has demonstrated reliability and validity, including with oncology samples.
Query!
Assessment method [1]
330541
0
Query!
Timepoint [1]
330541
0
3 and 6 months post recruitment
Query!
Secondary outcome [2]
330542
0
Secondary outcome 2 (Service provider costs). The service provider costs due to the uptake of referrals and differences in the length and frequency of calls for both groups (Treatment as Usual and Structured Care ) will be tracked through the Cancer Council client record systems and standard hourly costs applied to provide a full assessment of the cost implications for each of the care models.
Query!
Assessment method [2]
330542
0
Query!
Timepoint [2]
330542
0
3 and 6 months post-recruitment
Query!
Eligibility
Key inclusion criteria
Eligible participants will be Cancer Council 13 11 20 Information and Support Service callers who: reside in New South Wales or Victoria; are 18 years or older; have been diagnosed with cancer or cares for someone with cancer (such as a significant other); have a Distress Thermometer score of 4 or more; and consent to telephone follow-up.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Callers who express suicidal ideation are managed according to internal response protocols and may be excluded from study participation.
Query!
Study design
Purpose of the study
Educational / counselling / training
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Following a stepped-wedge design, consultants will be randomised to deliver either Treatment as Usual or Structured Care with all consultants delivering Structured Care at study completion. Allocation of consultants will be concealed when randomised at the start of the second 6-months time point and completed via an allocation schedule held off-site.
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation using a randomisation table created by computer software (i.e. computerised sequence generation) at the 6 months time-point after study commencement.
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
The people assessing the outcomes
The people analysing the results/data
Query!
Query!
Query!
Query!
Intervention assignment
Other
Query!
Other design features
This trial is a stepped wedge design with all: a) consultants delivering Treatment as Usual for the first six months; b)half of consultants randomised to deliver Structured Care for the second 6 month data collection period; and, c) all remaining consultants delivering Structured Care for the last 6 month data collection period.
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Descriptive statistics will be used to assess referral uptake rates. Differences between GHQ-28 scores for the intervention and comparison group will be tested using a generalised linear model. The outcome in the models will be the GHQ-28 scores at 3 and 6 months, and the model will include terms for the intervention group, the interaction between the intervention group and time, which will allow the effect of the intervention on the outcome to be different at 3 and 6 months. A comparative effectiveness analysis will be completed to assess the differences in service provider costs between the two groups.
The trial aims to recruit a total of 1512 participants; this represents approximately 63 callers per consultant for each 6-month time period in the stepped wedge design and accounts for a 70% consent rate with 10% attrition at each data collection period. This sample size will provide the study with approximately 80% power to detect a difference of 0.3 standard deviations in the mean score of the GHQ-28 between the two study groups at an alpha level of 0.05 and assuming an intra-cluster correlation of 0.04. Effect sizes of 0.3 standard deviations or greater have been achieved in psychosocial support interventions using the GHQ-28 as an outcome measure.
Query!
Recruitment
Recruitment status
Active, not recruiting
Query!
Date of first participant enrolment
Anticipated
17/04/2017
Query!
Actual
15/05/2017
Query!
Date of last participant enrolment
Anticipated
30/06/2019
Query!
Actual
12/09/2019
Query!
Date of last data collection
Anticipated
30/04/2020
Query!
Actual
Query!
Sample size
Target
1512
Query!
Accrual to date
Query!
Final
1345
Query!
Recruitment in Australia
Recruitment state(s)
NSW,VIC
Query!
Funding & Sponsors
Funding source category [1]
295282
0
Government body
Query!
Name [1]
295282
0
NHMRC
Query!
Address [1]
295282
0
GPO Box 1421 Canberra ACT 2601
Query!
Country [1]
295282
0
Australia
Query!
Funding source category [2]
295283
0
Other
Query!
Name [2]
295283
0
Cancer Council NSW
Query!
Address [2]
295283
0
153 Dowling St, Woolloomooloo NSW 2011
Query!
Country [2]
295283
0
Australia
Query!
Funding source category [3]
295284
0
Other
Query!
Name [3]
295284
0
Cancer Council Vic
Query!
Address [3]
295284
0
615 St Kilda Rd, Melbourne VIC 3004
Query!
Country [3]
295284
0
Australia
Query!
Primary sponsor type
University
Query!
Name
University of Newcastle
Query!
Address
University Dr, Callaghan NSW 2308
Query!
Country
Australia
Query!
Secondary sponsor category [1]
294105
0
Other Collaborative groups
Query!
Name [1]
294105
0
Hunter Medical Research Institute
Query!
Address [1]
294105
0
1/1 Kookaburra Circuit, New Lambton Heights NSW 2305
Query!
Country [1]
294105
0
Australia
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
296614
0
University of Newcastle
Query!
Ethics committee address [1]
296614
0
University Dr, Callaghan NSW 2308
Query!
Ethics committee country [1]
296614
0
Australia
Query!
Date submitted for ethics approval [1]
296614
0
27/05/2016
Query!
Approval date [1]
296614
0
18/07/2016
Query!
Ethics approval number [1]
296614
0
H-2016-0180
Query!
Ethics committee name [2]
296616
0
Cancer Council NSW
Query!
Ethics committee address [2]
296616
0
153 Dowling St, Woolloomooloo NSW 2011
Query!
Ethics committee country [2]
296616
0
Australia
Query!
Date submitted for ethics approval [2]
296616
0
17/05/2016
Query!
Approval date [2]
296616
0
29/06/2016
Query!
Ethics approval number [2]
296616
0
304
Query!
Ethics committee name [3]
296617
0
Cancer Council Victoria
Query!
Ethics committee address [3]
296617
0
153 Dowling St, 615 St Kilda Rd, Melbourne VIC 3004
Query!
Ethics committee country [3]
296617
0
Australia
Query!
Date submitted for ethics approval [3]
296617
0
09/06/2016
Query!
Approval date [3]
296617
0
05/08/2016
Query!
Ethics approval number [3]
296617
0
1605
Query!
Summary
Brief summary
The aim of this study is to evaluate whether a two-step distress screening process and a referral model can improve individuals’ use of supportive services and reduce their levels of distress after contacting the Cancer Council 13 11 20 Information and Support line.
Who is it for?
You may be eligible to join this study if you aged 18 years or above, have been diagnosed with cancer or care for someone with cancer, reside in Victoria or New South Wales, and are telephoning the Cancer Council 13 11 20 line.
Study details
Individuals affected by cancer (patients, family members, or friends) who call the Cancer Council New South Wales (NSW) or Victoria 13 11 20 services will receive distress screening as part of routine practice. CIS consultants will be randomised to deliver either: i) Treatment as Usual - provision of information, referral to emotional support or instrumental services based on a single distress question and consultants’ judgement; or ii) Structured care – an additional 4 screening questions and a referral model, based on the caller’s level of distress. Participants will be contacted at 3 and 6 months after this call to complete a survey exploring distress levels, service use, and the impact of health education.
Structured care is not yet a feature of community-level cancer support services. The new knowledge that would be produced by this study will directly inform decisions about whether or not such a model is adopted by Cancer Councils in NSW and Victoria. The project will directly contribute to improving the performance of telephone support services for cancer patients nationally and internationally.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
71478
0
Prof Christine L Paul
Query!
Address
71478
0
W4 Hunter Medical Research Institute Building
1 Kookaburra Circuit
New Lambton Heights , NSW, 2305
Query!
Country
71478
0
Australia
Query!
Phone
71478
0
+61 2 40420693
Query!
Fax
71478
0
Query!
Email
71478
0
[email protected]
Query!
Contact person for public queries
Name
71479
0
Dr Elizabeth Fradgley
Query!
Address
71479
0
W4 Hunter Medical Research Institute Building
1 Kookaburra Circuit
New Lambton Heights , NSW, 2305
Query!
Country
71479
0
Australia
Query!
Phone
71479
0
+61 2 40420642
Query!
Fax
71479
0
Query!
Email
71479
0
[email protected]
Query!
Contact person for scientific queries
Name
71480
0
Prof Christine L Paul
Query!
Address
71480
0
W4 Hunter Medical Research Institute Building,
1 Kookaburra Circuit,
New Lambton Heights , NSW, 2305
Query!
Country
71480
0
Australia
Query!
Phone
71480
0
+61 2 40420693
Query!
Fax
71480
0
Query!
Email
71480
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
ethical considerations and data management policy, please email scientific contact.
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF